DE69226487T2 - Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten - Google Patents

Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten

Info

Publication number
DE69226487T2
DE69226487T2 DE69226487T DE69226487T DE69226487T2 DE 69226487 T2 DE69226487 T2 DE 69226487T2 DE 69226487 T DE69226487 T DE 69226487T DE 69226487 T DE69226487 T DE 69226487T DE 69226487 T2 DE69226487 T2 DE 69226487T2
Authority
DE
Germany
Prior art keywords
autoimmune diseases
hydrogen
prevention
treatment
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69226487T
Other languages
English (en)
Other versions
DE69226487D1 (de
Inventor
Mitsuru Naiki
Yuichi Takeoka
Seishi Suehiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of DE69226487D1 publication Critical patent/DE69226487D1/de
Application granted granted Critical
Publication of DE69226487T2 publication Critical patent/DE69226487T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69226487T 1991-09-26 1992-09-23 Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten Expired - Fee Related DE69226487T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27654391 1991-09-26

Publications (2)

Publication Number Publication Date
DE69226487D1 DE69226487D1 (de) 1998-09-10
DE69226487T2 true DE69226487T2 (de) 1999-02-18

Family

ID=17570946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226487T Expired - Fee Related DE69226487T2 (de) 1991-09-26 1992-09-23 Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten

Country Status (4)

Country Link
US (2) US5376682A (de)
EP (1) EP0534907B1 (de)
AT (1) ATE169217T1 (de)
DE (1) DE69226487T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0720607A1 (de) * 1993-09-17 1996-07-10 PHARMACIA & UPJOHN COMPANY Substituierte tetronsäuren zur behandlung von hiv und anderen retroviren
DE69626276T2 (de) * 1995-03-20 2003-11-13 Upjohn Co Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
ATE403714T1 (de) 1996-11-06 2008-08-15 Univ California Tumor necrosis factor rezeptor abspaltendes enzym,dessen zubereitungen und verwendungen
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US7323495B2 (en) 2002-11-05 2008-01-29 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
US20040119052A1 (en) * 2002-12-20 2004-06-24 Beavers William Anthony Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
WO2010009456A1 (en) * 2008-07-18 2010-01-21 Cornell University Mycobacterium tuberculosis rv3671c gene encoded membrane protease as a target for inhibitors of intrabacterial ph homeostasis and acid resistance
MX2011004331A (es) * 2008-10-24 2011-09-21 Magnachem Int Lab Inc Metodo para busqueda de compuestos que interactuan selectivamente con rad9.
US9073884B2 (en) * 2010-06-04 2015-07-07 The Regents Of The University Of California Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3232882A1 (de) * 1982-09-02 1984-03-08 Josef Dipl.-Chem. Dr.Rer.Nat. Klosa Neues analgetikum
US5045564A (en) * 1988-12-07 1991-09-03 Allergan, Inc. Anti-inflammatory 2-furanones

Also Published As

Publication number Publication date
DE69226487D1 (de) 1998-09-10
US5376682A (en) 1994-12-27
EP0534907B1 (de) 1998-08-05
US5532271A (en) 1996-07-02
ATE169217T1 (de) 1998-08-15
EP0534907A1 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
DE69402173T2 (de) Hemmung von Thrombin
NO981528L (no) Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet
ATE218864T1 (de) Verwendung von piperidin-derivaten in der behandlung von schizophrenie
GB9202791D0 (en) Compounds
ES2132393T3 (es) Derivados de guanidina utiles en terapeutica.
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
DE69226487D1 (de) Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE99934T1 (de) Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
ES2157961T3 (es) Inhibicion del hirsutismo y la alopecia en mujeres.
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ZA885358B (en) Uricosuric composition
DE3889532T2 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee